Princess Margaret Alumni

Dr. Jonathan Ledermann is a global authority in the field of gynecologic cancer, with experience in designing and leading several national and international clinical trials focused on targeted therapies, personalized medicine and immunotherapy for gynaecological cancer. His research and clinical efforts have changed the paradigm of care in these cancers and his efforts today continue to push the boundaries of our knowledge and practice.

Dr. Ledermann completed a clinical research fellowship in medical oncology at the Princess Margaret Cancer Centre from 1987-1988, with a focus on the treatment of gynecological cancers. It was through his fellowship that Dr. Ledermann established a firm interest in gynecological oncology, leading exceptional contributions to research in the field of gynecological cancer for over 35 years.

Christophe Le Tourneau spent a two-year Clinical Research Fellowship at the Princess Margaret from 2007 to 2009. During this time, he completed and published nine manuscripts. Upon completion of his fellowship, Dr. Le Tourneau returned to Paris, France where he successfully established a Phase I Clinical Trials unit and became leader of the Head and Neck Oncology Unit at the Institut Curie. The knowledge and skill sets he acquired during his time at the Princess Margaret have enabled him to gain recognition in the field and initiate many new ideas and concepts. During his fellowship, he was exposed to multidisciplinary collaborations and this experience has enabled him to endorse team science throughout his research career.

Dr. Le Tourneau is now senior Medical Oncologist at the Institut Curie and Professor of Medicine at Paris-Saclay University. He heads the Department of Drug Development and Innovation as well as the Head and Neck Clinic. Dr. Le Tourneau also leads the early phase clinical trials program of the Institut Curie. His main interests are precision medicine, phase I clinical trials with a special attention at the methodology to conduct these trials, as well as Head and Neck oncology. Dr. Le Tourneau leads several precision medicine projects at the national and international level. He has published 170+ peer-reviewed papers in international journals.

Prof. Selby was a research fellow at the Princess Margaret in the early 1980’s and has always credited his experience here as a key stimulus for his ongoing commitment to cancer research. He had an illustrious career in cancer research as Professor of Cancer Medicine at the University of Leeds and went on to hold multiple leadership positions in the UK and Europe. Prof. Selby’s work on promoting universal access to clinical research in the UK and Canada led to the recognition of clinical trials as a powerful way of improving cancer outcomes. He was one of the main architects of the European Code of Cancer Practice, a citizen and patient-centred manifesto of the core requirements for good clinical cancer practice, published in 2021.

Prof. Selby continues to work with the European Cancer Organisation and the European School of Oncology to promote strategic approaches to improving cancer outcomes and train a new generation of oncologists. With a career that has spanned clinical research, education, academic leadership and cancer system leadership in the United Kingdom, Europe and Canada, Prof. Selby remains an example of what can be achieved by one person with talent, integrity, perseverance and dedication to patients.